TMEM158 and central nervous system cancer: The results showed that glioma cell migration ability was enhanced when TMEM158 expression was upregulated (p < 0.001) (Fig. 3I, K), while downregulating TMEM158 expression significantly decreased the motility of glioma cell (p < 0.001) (Fig. 3J, L).